Hanall Biopharma, 1Q Operating Profit 4.5 Billion KRW... 80% Increase YoY

[Asia Economy Reporter Minwoo Lee] HanAll Biopharma announced on the 29th that it posted provisional results for the first quarter of this year with consolidated sales of 27.8 billion KRW and operating profit of 4.5 billion KRW. This represents increases of 25.8% and 80.4%, respectively, compared to the same period last year. Net profit for the period was recorded at 4.5 billion KRW, up 12.5% during the same period.

This content was produced with the assistance of AI translation services.